Comparison Overview

CSL

VS

ICON plc

CSL

655 Elizabeth St, Melbourne, 3000, AU
Last Update: 2026-04-02
View Profile
Between 800 and 849
https://www.csl.com/

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 23,312
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

ICON plc

ICON plc, South County Business Park, Leopardstown, Dublin, IE, D18 X5R3
Last Update: 2026-04-02
Between 750 and 799
http://www.iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 34,531
Subsidiaries: 9
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/csl.jpeg
CSL
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/icon-plc-2.jpeg
ICON plc
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
CSL
100%
Compliance Rate
0/4 Standards Verified
ICON plc
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for CSL in 2026.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for ICON plc in 2026.

Incident History — CSL (X = Date, Y = Severity)

CSL cyber incidents detection timeline including parent company and subsidiaries

Incident History — ICON plc (X = Date, Y = Severity)

ICON plc cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/csl.jpeg
CSL
Incidents

No Incident

https://images.rankiteo.com/companyimages/icon-plc-2.jpeg
ICON plc
Incidents

No Incident

FAQ

CSL company demonstrates a stronger AI Cybersecurity Score compared to ICON plc company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, ICON plc company has disclosed a higher number of cyber incidents compared to CSL company.

In the current year, ICON plc company and CSL company have not reported any cyber incidents.

Neither ICON plc company nor CSL company has reported experiencing a ransomware attack publicly.

Neither ICON plc company nor CSL company has reported experiencing a data breach publicly.

Neither ICON plc company nor CSL company has reported experiencing targeted cyberattacks publicly.

Neither CSL company nor ICON plc company has reported experiencing or disclosing vulnerabilities publicly.

Neither CSL nor ICON plc holds any compliance certifications.

Neither company holds any compliance certifications.

ICON plc company has more subsidiaries worldwide compared to CSL company.

ICON plc company employs more people globally than CSL company, reflecting its scale as a Biotechnology Research.

Neither CSL nor ICON plc holds SOC 2 Type 1 certification.

Neither CSL nor ICON plc holds SOC 2 Type 2 certification.

Neither CSL nor ICON plc holds ISO 27001 certification.

Neither CSL nor ICON plc holds PCI DSS certification.

Neither CSL nor ICON plc holds HIPAA certification.

Neither CSL nor ICON plc holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

A vulnerability was found in Nothings stb up to 1.26. Impacted is the function stbtt_InitFont_internal in the library stb_truetype.h of the component TTF File Handler. Performing a manipulation results in out-of-bounds read. Remote exploitation of the attack is possible. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published
Date
2026-04-01
Updated
Date
2026-04-01
Risk Information
cvss2
Base: 5.0
Severity: LOW
AV:N/AC:L/Au:N/C:N/I:N/A:P
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:L
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read in VS6ComFile!get_macro_mem_COM. Opening a crafted V7 file may lead to information disclosure from the affected product.

Published
Date
2026-04-01
Updated
Date
2026-04-01
Risk Information
cvss3
Base: 7.8
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
cvss4
Base: 8.4
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

V-SFT versions 6.2.10.0 and prior contain a stack-based buffer overflow in VS6ComFile!CSaveData::_conv_AnimationItem. Opening a crafted V7 file may lead to arbitrary code execution on the affected product.

Published
Date
2026-04-01
Updated
Date
2026-04-01
Risk Information
cvss3
Base: 7.8
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
cvss4
Base: 8.4
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read vulnerability in VS6MemInIF!set_temp_type_default. Opening a crafted V7 file may lead to information disclosure from the affected product.

Published
Date
2026-04-01
Updated
Date
2026-04-01
Risk Information
cvss3
Base: 7.8
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
cvss4
Base: 8.4
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

V-SFT versions 6.2.10.0 and prior contain an out-of-bounds read vulnerability in VS6ComFile!load_link_inf. Opening a crafted V7 file may lead to information disclosure from the affected product.

Published
Date
2026-04-01
Updated
Date
2026-04-01
Risk Information
cvss3
Base: 7.8
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
cvss4
Base: 8.4
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References